MedTrace Logo

Study on the Effects of Resistant Potato Starch on Gut Bacteria in Healthy Adults

NCT06949631 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2025-11-20

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate how taking Resistant Potato Starch affects the gut microbiota compared to a placebo, in healthy adults. Over a 4-week period, participants will provide stool samples for analysis to detect any changes in gut bacteria. They will also record daily information in a diary about their stool consistency, frequency, digestive symptoms, and overall quality of life.

Conditions

  • Gastrointestinal Microbiota

Interventions

DIETARY_SUPPLEMENT

Resistant Potato Starch

Active Ingredients: 3.5 g potato starch Inactive ingredients: 3.5 g corn starch

OTHER

Placebo

Active Ingredients: N/A Inactive Ingredients: 7 g corn starch

Sponsors & Collaborators

  • Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

    collaborator NETWORK

  • MSP Starch Products Inc.

    lead INDUSTRY

Principal Investigators

  • Jason Bush, Chief Scientific Officer · MSP Starch Products Inc.

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-29
Primary Completion
2025-10-03
Completion
2025-10-03

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06949631 on ClinicalTrials.gov